Skip to main content
Survivorship: Immunizations and Prevention of Infections, Version 2.2014 JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Den Linger, C. S., Ligibel, J. A., Are, M., Baker, K. S., Demark-Wahnefried, W., Dizon, D., Friedman, D. L., Goldman, M., Jones, L., King, A., Ku, G. H., Kvale, E., Langbaum, T. S., Leonardi-Warren, K., McCabe, M. S., Melisko, M., Montoya, J. G., Mooney, K., Morgan, M. A., Moslehi, J. J., O'Connor, T., Overholser, L., Paskett, E. D., Peppercorn, J., Raza, M., Rodriguez, M. A., Syrjala, K. L., Urba, S. G., Wakabayashi, M. T., Zee, P., McMillian, N. R., Freedman-Cass, D. A. 2014; 12 (8): 1098-1111

Abstract

Cancer survivors are at an elevated risk for infection because of immune suppression associated with prior cancer treatments, and they are at increased risk of complications from vaccine-preventable diseases. This section of the NCCN Guidelines for Survivorship provides recommendations for the prevention of infections in survivors through education, antimicrobial prophylaxis, and the judicious use of vaccines. These guidelines provide information about travel and gardening precautions and safe pet care/avoidance of zoonosis, and include detailed recommendations regarding vaccinations that should be considered and encouraged in cancer and transplant survivors.

View details for Web of Science ID 000340218200004

View details for PubMedID 25099442